Search results for "Potency"

showing 10 items of 122 documents

Comparison of the immunosuppressive efficacy of 6-mercaptopurine, azathioprine, cyclophosphamide and 036.5122 (Asta) on the primary and secondary imm…

1976

Two alkylating (cyclophosphamide and 036.5122 Asta) and two antiproliferative agents (6-mercaptopurine and azathioprine) have been compared for their immuno-suppressive potency on the primary and secondary humoral immune response of mice. If equitoxic dosages of the respective drugs are compared, the alkylating agents proved to be of much higher immunosuppressive potency than the antiproliferative agents. In non toxic dosages alkylating agents were able to completely inhibit a primary or secondary immune response, whilst a similar effect with antiproliferative drugs could not be obtained even within toxic dose ranges. Induction of immunological tolerance was possible only by use of the alky…

MaleAllergyErythrocytesTime FactorsDoseCyclophosphamidemedicine.medical_treatmentImmunologyAzathioprineViral Plaque AssayPharmacologyBiologyToxicologyLethal Dose 50MiceImmune systemAzathioprineImmune TolerancemedicineAnimalsPotencyPharmacology (medical)CyclophosphamidePharmacologyMercaptopurineImmunityImmunosuppressionmedicine.diseaseMercaptopurineImmunologyFemaleImmunosuppressive Agentsmedicine.drugAgents and Actions
researchProduct

Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice

2000

Distinguishing the specific effects of neuroleptics on one particular behaviour from its non-specific effects on motility is not easy. In this study, the effects of five neuroleptics on spontaneous motor activity were compared and the ED(50) values of these drugs to impair activity were calculated. Male and female mice were evaluated in an actimeter or in a shuttle-box used as an open field after the administration of chlorpromazine (0.4, 1.2, 3.6 mg/kg), haloperidol (0.1, 0.3, 0.9 mg/kg), raclopride (0.1, 0.3, 0.9 mg/kg), sulpiride (10, 30, 90 mg/kg) and clozapine (0.4, 1.2, 3.6 mg/kg), and two automatic and two observational activity measures were obtained. A very high correlation between…

MaleChlorpromazineMotor ActivityPharmacologyOpen fieldMiceHaloperidolAnimalsMedicinePotencyPharmacology (medical)Motor activityChlorpromazineClozapineBiological PsychiatryClozapinePharmacologyRaclopridebusiness.industryPsychiatry and Mental healthNeurologyRacloprideHaloperidolFemaleNeurology (clinical)SulpiridebusinessSulpirideAntipsychotic Agentsmedicine.drugEuropean Neuropsychopharmacology
researchProduct

Kinetics of the reactive cell clones after immunosuppression and induction of tolerance: (1) Inhibition of 19 S and 7 S plaque-forming cells in the p…

1975

The kinetics of the reactive cell clones after primary and secondary immunization with SRBC1) modified by cyclophosphamide and a newly synthesized cyclophosphamide analogue 036.5122 (Asta), have been studied. After primary immunization, both substances caused a severe and dose dependent depletion of 19 S PFC2). The 7 S PFC in the late primary response were only slightly inhibited by cyclophosphamide in low dose ranges, indicating, that sensitization could not be prevented by this substance. In contrast, 0.36.5122 was fully able to suppress 7 S PFC. Thus, treatment with 0.36.5122 after primary immunization can fully prevent the expression of the specific response. Experiments dealing with in…

MaleErythrocytesCyclophosphamidemedicine.medical_treatmentImmunologyCellHemolytic Plaque TechniqueMice Inbred StrainsBiologyToxicologyMiceAntigenImmune TolerancemedicineAnimalsPotencyCytotoxic T cellPharmacology (medical)Cells CulturedSensitizationImmunosuppression TherapyPharmacologyImmunity CellularImmunosuppressionClone Cellsmedicine.anatomical_structureImmunizationImmunologyFemaleSpleenmedicine.drugAgents and Actions
researchProduct

Quality and potency profile of eight recombinant isoallergens, largely mimicking total Bet v 1-specific IgE binding of birch pollen.

2019

Background To date, only limited information on structure, expression levels and IgE binding of Bet v 1 variants, which are simultaneously expressed in birch pollen, is available. Objective To analyse and compare structure and serum IgE/IgG binding of rBet v 1 variants to Bet v 1.0101. Methods Recombinant Bet v 1 variants were studied with sera of 20 subjects allergic to birch pollen. Folding, aggregation and solubility of the rBet v 1 variants were analysed to attribute diverging IgE binding to either allergen structure or methodological features. IgE/IgG binding was studied with rBet v 1 in solution or adsorbed to solid phases. Allergen-mediated cross-linking of FceRI receptors was determ…

MaleImmunologyEnzyme-Linked Immunosorbent AssayBasophilImmunoglobulin Emedicine.disease_causeMass Spectrometrylaw.inventionAllergenlawmedicineImmunology and AllergyPotencyAnimalsHumansReceptorBetulaPlant ProteinsbiologyChemistrySpectrum AnalysisRhinitis Allergic SeasonalHypoallergenicAntigens PlantImmunoglobulin EMolecular biologyRecombinant ProteinsRatsmedicine.anatomical_structureIgG bindingImmunoglobulin Gbiology.proteinRecombinant DNAPollenFemaleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
researchProduct

A new alternative in vitro method for quantification of Toxoplasma gondii infectivity.

2011

An in vitro method to determine the infectious potency of an unknown suspension of the protozoan parasite Toxoplasma gondii based on kinetics of host cells lysis was developed. Mic1-3KO a mutant strain of T. gondii RH tachyzoites was inoculated in 25-cm² flasks containing a 90% confluent monolayer of human foreskin fibroblasts. Lysis kinetics was monitored for infection ratios ranging from 1∶10⁶ to 1∶10; we defined 10⁶ tachyzoites/ml⁻¹ as the threshold value for parasite egress. Results allowed us to build a calibration curve relating the initial infection ratios to the time needed to reach 10⁶ tachyzoites/ml⁻¹. Finally, we validated the method using a known mixture of dead and live parasit…

MaleLysisTime FactorsForeskinModels BiologicalMicrobiologyCell LineForeskinmedicineParasite hostingPotencyHumansEcology Evolution Behavior and SystematicsInfectivitybiologyCell DeathToxoplasma gondiiReproducibility of ResultsFibroblastsbiology.organism_classificationVirologyIn vitroGenetically modified organismKineticsmedicine.anatomical_structureCalibrationParasitologyToxoplasmaThe Journal of parasitology
researchProduct

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

2019

Background: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic disorder across Europe and explore whether differences in such patterns contribute to variations in the incidence rates of psychotic disorder. Methods: We included patients aged 18–64 years who presented to psychiatric services in 11 sites across Europe and Brazil with first-episode psychosis and recruited controls representative of the local populations. We applied adjusted logistic regression models to the data to estimate which patterns of canna…

MaleMarijuana Abusecannabis psychosis first episode psychosis incidenceENGLANDHIGH-POTENCY CANNABIS0302 clinical medicineSCHIZOPHRENIAOdds RatioMedicine030212 general & internal medicinepsychosisSalut mentalRISKeducation.field_of_studybiologyIncidence (epidemiology)IncidenceArticlesASSOCIATIONMiddle Aged3. Good healthEuropePsychiatry and Mental healthPUBLIC-HEALTHFemaleCase-Control StudieBrazilHumanAdultmedicine.medical_specialtyPsychosisPopulationPsychotic DisorderOdds03 medical and health sciencesYoung Adultfirst episode psychosisJournal ArticleHumanseducationSettore MED/25 - PsichiatriaBiological PsychiatryCannabisbusiness.industryLONDONPublic healthCase-control studyOdds ratiobiology.organism_classificationmedicine.diseaseTRENDS030227 psychiatryPsychotic DisordersMARIJUANACase-Control StudiesCannabisDroguesbusinessDemography
researchProduct

Altered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatment

2013

Background: According to both in vitro and in vivo data P-glycoprotein (P-gp) may restrict the uptake of several antidepressants into the brain, thus contributing to the poor success rate of current antidepressant therapies. The therapeutic activity of citalopram resides in the Senantiomer, whereas the R-enantiomer is practically devoid of serotonin reuptake potency. To date, no in vivo data are available that address whether the enantiomers of citalopram and its metabolites are substrates of P-gp. Methods: P-gp knockout (abcb1ab (-/-)) and wild-type (abcb1ab (+/+)) mice underwent acute (single-dose) and chronic (two daily doses for 10 days) treatment with citalopram (10 mg/kg) or escitalop…

MaleMedicin och hälsovetenskapescitalopramenantiomersCitaloprammice knockoutP-glycoproteinCitalopramPharmacologyMedical and Health Sciencesbehavioral disciplines and activitiesMiceIn vivomental disordersmedicineAnimalsEscitalopramPotencyPharmacology (medical)ATP Binding Cassette Transporter Subfamily B Member 1Biological PsychiatryP-glycoproteinMice KnockoutPharmacologybiologybusiness.industryBrainPsychiatry and Mental healthNeurologyKnockout mousebiology.proteinAntidepressive Agents Second-GenerationAntidepressantNeurology (clinical)Enantiomerbusinessmedicine.drugEuropean Neuropsychopharmacology
researchProduct

Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton

2006

In our studies on the development of new anticonvulsants, we planned the synthesis of N-substituted 1,2,3,4-tetrahydroisoquinolines to explore the structure-activity relationships. All derivatives were evaluated against audiogenic seizures in DBA/2 mice, and the 1-(4'-bromophenyl)-6,7-dimethoxy-2-(piperidin-1-ylacetyl) derivative (26) showed the highest activity with a potency comparable to that of talampanel, the only noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonist in clinical trials as an anticonvulsant agent. Electrophysiological experiments indicated that 26 acts as noncompetitive AMPA receptor modulator.

MaleStereochemistrymedicine.medical_treatmentAMPA receptorIn Vitro TechniquesChemical synthesisMiceStructure-Activity Relationshipchemistry.chemical_compoundPiperidinesSeizuresTetrahydroisoquinolinesAMPADrug DiscoverymedicineAnimalsPotencyReceptors AMPARats WistarTalampanelTetrahydroisoquinolineAntagonistAMPA; Isoquinolines; anticonvulsantsOlfactory PathwaysIsoquinolinesRatsAnticonvulsant AgentAnticonvulsantAcoustic StimulationchemistryMice Inbred DBAMolecular MedicineAnticonvulsants
researchProduct

Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats

1977

Abstract The elimination, distribution and anticoagulant activity of S(—)-, R(+)-, and R,S(±)-phenprocoumon were determined in male Wistar-Lewis rats after intravenous injection of a single dose of 0·6 mg kg−1. From the plasma concentrations which elicited the same anticoagulant effect, S(—)-phenprocoumon was 4 to 5 times more potent than R(+)-phenprocoumon. The potency of the racemate was between those of the enantiomers. The mean biologic half-life of the S(—)-enantiomer was shorter (12·5 h) than that of R(+)-phenprocoumon (17·8 h). No differences were observed in the apparent volume of distribution. However, the mean liver: plasma concentration ratio was higher for the S(—)-(6·9) than fo…

MaleTime Factorsmedicine.drug_classPharmaceutical ScienceIn Vitro TechniquesPharmacologyPhenprocoumonPharmacokineticsmedicineAnimalsPotencyDistribution (pharmacology)PharmacologyVolume of distributionChemistryAnticoagulantAnticoagulantsRats Inbred StrainsStereoisomerism4-HydroxycoumarinsBlood ProteinsRatsKineticsLiverPhenprocoumonStereoselectivityBlood Coagulation TestsEnantiomerProtein Bindingmedicine.drugJournal of Pharmacy and Pharmacology
researchProduct

Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

2019

International audience; Self-renewal and differentiation of pluripotent murine embryonic stem cells (ESCs) is regulated by extrinsic signaling pathways. It is less clear whether cellular metabolism instructs developmental progression. In an unbiased genome-wide CRISPR/Cas9 screen, we identified components of a conserved amino-acid-sensing pathway as critical drivers of ESC differentiation. Functional analysis revealed that lysosome activity, the Ragulator protein complex, and the tumor-suppressor protein Folliculin enable the Rag GTPases C and D to bind and seclude the bHLH transcription factor Tfe3 in the cytoplasm. In contrast, ectopic nuclear Tfe3 represses specific developmental and met…

MaleTranscription GeneticGTPaseGTP PhosphohydrolasesPATHWAYMice0302 clinical medicineNeural Stem CellsCRISPRTUMOR-SUPPRESSORCell Self RenewalPhosphorylationSPECIFICATIONdevelopmental disorder0303 health sciencesGenomeBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell DifferentiationMouse Embryonic Stem CellsFlcndifferentiationCell biologymedicine.anatomical_structuremTORMolecular MedicineFemaleSignal transductionProtein BindingSignal TransductionRECRUITMENTBiology03 medical and health sciencesRag GTPasesLysosomeGeneticsmedicineAnimalsHumansPoint MutationNAIVE PLURIPOTENCYAMINO-ACID LEVELSTranscription factorAllelesPI3K/AKT/mTOR pathway030304 developmental biologyCOMPLEXFOLLICULINRagulatorCell Biologypluripotencyembryonic stem cellEmbryonic stem cellTfe3[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsCytoplasmLysosomes030217 neurology & neurosurgeryCell Stem Cell
researchProduct